Market Overview

Bacterin Issued Patent for Method to Produce Demineralized Bone Matrix


Bacterin International Holdings (NYSE: BONE) today announced that the United States Patent and
Trademark Office has issued US Patent No. 8,574,825 entitled “Process
for Demineralization of Bone Matrix with Preservation of Natural Growth
Factors.” The issued claims in the patent are for a method to produce a
demineralized cancellous bone matrix, such as Bacterin's OsteoSponge®
product line. Bacterin has a pending divisional application in the
United States to pursue protection on other aspects of its bone
demineralization technology and is pursuing protection on related
applications in Canada, Europe, and Korea.

Gregory Juda, Bacterin's CSO, commented “We are pleased

See full press release

Posted-In: News Guidance Contracts Legal Management M&A Global


Related Articles (BONE)

View Comments and Join the Discussion!

Partner Center